Geoffrey Ginsburg is chief medical and scientific officer for the All of Us Research Program at the National Institutes of Health, where he leads scientific vision and strategy for the program. Previously, Ginsburg was founding director of the Center for Applied Genomics and Precision Medicine at Duke University School of Medicine and held senior leadership roles at Millennium Pharmaceuticals Inc. He has influenced precision medicine in the United States and internationally, serving as co-chair of the National Academies’ Roundtable on Genomic and Precision Health, as a founding co-chair of the International HundredK+ Cohorts Consortium, and as founder and president of the Global Genomic Medicine Collaborative (G2MC).
Previously
Managing disease is getting personal. With the genomic revolution upon us, we now understand that many diseases don't always follow the same predictable course and personalize...